How to use tafasitamumab and how to arrange the treatment cycle?

Tafaracetamumab is an intravenous injection preparation. It is generally used in combination with lenalidomide in the early stage of treatment and is infused 1 to 2 times per week, with the specific frequency listed first3 In the span> period, it is 3 times a week, and from the 4 period, it is changed to once every two weeks until the 12th period. Thereafter, if the patient tolerates the drug well and the disease is stable, single-agent maintenance therapy can be maintained until disease progression or severe side effects occur. Each infusion time is generally 1.5 to 3 hours. The first dose may take longer to observe whether there are any adverse reactions. The treatment location must be in a hospital or a qualified medical institution. The doctor will calculate the dosage according to the patient's weight and monitor blood, liver and kidney functions. The entire course of treatment may last several months, and PET-CT or other imaging tests need to be reviewed regularly during treatment to evaluate the efficacy.